Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access - Hims & Hers Health (NYS

Hims & Hers CEO Andrew Dudum defends the firm against an FTC lawsuit, discusses dropping GLP-1 drug prices and reveals in-house AI plans.

Raccontata dabenzinga.com